Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.
A phase 2 trial registered on ClinicalTrials.gov. The registry status is enrolling by invitation. It plans to enroll 600 participants.
Also called NCT03389100
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase
- Phase 2
- Enrolled
- 600 participants
- Registry
-
NCT03389100
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Enrolling by invitation
Technical summary
Registry record NCT03389100. Allocation not applicable; no masking; primary purpose diagnostic. Start 2018-07-24 (actual); primary completion 2026-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Tau PET Imaging in the Northern Manhattan Study of Metabolism and Mind.
- Acronym
- NOMEM-Tau
- Condition
- Diabetes Mellitus, Type 2
- Condition
- Pre-diabetes
- Intervention (Drug)
- 18F-MK6240 injection
- Lead sponsor
- Columbia University
- Collaborator
- Hebrew Home at Riverdale
- Collaborator
- National Institute on Aging (NIA)
Record details
- Record id
cardio:ct-nct03389100- Content hash
017ea7deb428a789ea36755a4c6ca963a1f127a724eb71dda64775ffaffdbdaf